1 Min Read
July 20 (Reuters) - Astrazeneca Plc:
* Kyntheum approved in EU for treatment of adults with moderate-to-severe plaque psoriasis Further company coverage: (Bangalore.email@example.com)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.